AdvanSix (960) Q3 2026 Earnings Report
DE:960 Q3 2026 EPS Results
- Actual EPS
- -EUR 0.21
- Consensus EPS
- -EUR 0.04
- Beat/Miss
- Missed by -EUR 0.17
- One Year Ago EPS
- EUR 0.07
DE:960 Q3 2026 Revenue Results
- Actual Revenue
- EUR 382.79M
- Expected Revenue
- EUR 378.52M
- Beat/Miss
- Beat by +EUR 4.27M
- YoY Revenue Growth
- +15.04%
Earnings Announcement Details
- Quarter
- Q3 2026
- Date
- 11/04/2026
- Time
- Before Open
- Conference Call
- Wednesday, November 4, 2026
AdvanSix's next earnings date is estimated for February 12, 2027, based on past reporting schedules.
Q3 2026 Earnings Call Audio
Q3 2026 Earnings Slide Deck
Q3 2026 Earnings Call Summary
The call was positive but mixed. Strong pricing execution, sales growth, improved operating cash flow, working capital discipline, cost reduction progress, product growth in nylon resin and Chemical Intermediates, and attractive strategic growth projects outweighed the lower EBITDA, negative year-to-date free cash flow, reduced caprolactam volumes, and significant sulfur, benzene, and other raw material headwinds.
AdvanSix expects full year 2026 effective tax rate to be approximately 20%, full year 2026 CapEx of approximately $90 million, comprised of $75 million of base capital and $15 million of high-return growth investments, ammonia sales up 25% for the full year, nylon resin production output about 5% higher year-over-year, and strong domestic granular ammonium sulfate volume performance for the full 2026-2027 fertilizer year; the company anticipates a price over raws headwind year-over-year in the fourth quarter, tighter domestic ammonium sulfate supply and improved demand in the first half of 2027, and a higher pre-buy compared to the prior year, while seeing a path forward to break-even free cash flow in the calendar year, excluding the expected $18 million 45Q refund. Project CENTURY is a planned $98 million multi-year investment through 2031 expected to add approximately 84,000 tons of annual ammonia production, with $47 million in proposed USDA FIELDS funding, 2027 spend expected to be modest, peak spend in the 2029 to 2031 timeframe, and an IRR above the 20% target hurdle rate; preliminary capital planning for 2027 is to start around $80 million, the potential DEF project is expected to have a final investment decision in Q2 of 2027, and the company continues to progress its multi-year $30 million non-manpower fixed cost reduction program.
- Sales Growth Driven by PricingThird-quarter sales increased 15% year-over-year to $431 million, driven by 17% favorable pricing that more than offset a 2% decline in volume. Raw material pass-through pricing increased 10% and market-based pricing improved 7% across all product lines.
- Strong Commercial Execution and Margin ProtectionPricing actions nearly offset the substantial year-over-year increase in raw material costs. The company maintained margin expansion across Nylon Solutions and Chemical Intermediates, with pricing more than offsetting benzene and propylene impacts in those product lines.
- Improved Operating Cash Flow and Free Cash FlowCash flow from operations increased $21 million year-over-year to $48 million, primarily reflecting working capital discipline. Capital expenditures declined $8 million to $18 million, supporting $30 million of free cash flow in the quarter.
- Working Capital PerformanceThe cash conversion cycle continued to benchmark in the top quartile among peers. Working capital was a $24 million source of cash year-to-date, compared with a $56 million use of cash in the prior-year period, reflecting disciplined inventory optimization.
- Nylon Resin GrowthNylon resin sales increased 33% year-over-year, with resin volumes benefiting from improved operational performance at Chesterfield. Nylon resin production output was running about 5% higher year-over-year.
- Chemical Intermediates GrowthChemical Intermediates sales increased 24% year-over-year, supported by both price and volume improvement. Balanced acetone supply and demand and reduced imports into the U.S. continued to support spreads near cycle average levels.
- Plant Nutrients Volume OpportunityPlant Nutrients sales increased 8% year-over-year and 14% sequentially. The North American ammonium sulfate fall fill program was well received with strong volume interest, and the company expects strong domestic granular ammonium sulfate volume performance for the full 2026-2027 fertilizer year.
- Ammonia Sales and Production FlexibilityAmmonia sales are expected to increase 25% for the full year. The integrated ammonia platform provides flexibility to direct ammonia toward caprolactam, ammonium sulfate, SUSTAIN ammonium sulfate, merchant sales, or diesel exhaust fluid.
- Cost Reduction ProgressAdvanSix is progressing its multi-year $30 million non-manpower fixed cost reduction program and remains on track for year-one savings. SG&A contributed an approximately $3 million year-over-year benefit, reflecting disciplined cost management and the absence of the prior-year ERP upgrade investment.
- Operational Excellence and Reliability FocusThe company is prioritizing safe, stable, and sustainable operations through risk-based capital prioritization, disciplined turnaround scoping, continuous improvement, reliability initiatives, and optimization of product and geographic mix.
- Capital Spending and SUSTAIN ProgressFull-year 2026 capital expenditures are now expected to be approximately $90 million, consisting of $75 million of base capital and $15 million of high-return growth investments. The SUSTAIN ammonium sulfate project is being commissioned in the quarter, and the overall SUSTAIN program continues to exceed return expectations.
- Liquidity and Capital Deployment OptionalityThe new five-year, $425 million credit facility closed in August and consists of a revolver and term loan on comparable terms and conditions to the prior facility. Management said it provides ample liquidity for business needs and supports capital deployment optionality.
- Project CENTURY Funding and Expansion PotentialAdvanSix was selected to receive $47 million in proposed USDA FIELDS funding for Project CENTURY, one of eight projects selected. The planned $98 million multi-year investment through 2031 is expected to add approximately 84,000 tons of annual ammonia production, improve reliability and logistics, and modernize operations. Management expects the proposed grant to provide a nearly dollar-for-dollar match and said the project is expected to generate an IRR above the 20% target hurdle rate for discretionary investments.
- Favorable Ammonium Sulfate Supply OutlookManagement expects tighter domestic ammonium sulfate supply and improved demand in the first half of 2027. Several North American producers are reportedly not operating or are running intermittently, and management said the market is likely to be short of supply into the spring season.
- Stable End-Market Areas and Future Tax Credit OpportunityAutomotive, other consumer durable demand across engineering plastics applications, and packaging have remained relatively stable. Chemical Intermediates demand into construction, coatings, and downstream industrials has also been broadly stable. The company continues to pursue 45Q carbon capture tax credits as an opportunity to support future cash generation.
DE:960 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 12, 2027 | 2026 (Q4) | 0.47- | 0.03 | ― | ― |
| Nov 04, 2026 | 2026 (Q3) | -0.04-0.21 | 0.07 | -400.00% (-0.28) | |
| Aug 07, 2026 | 2026 (Q2) | 0.490.17 | 1.1 | -84.68% (-0.93) | |
| May 08, 2026 | 2026 (Q1) | -0.42-0.44 | 0.83 | -153.76% (-1.27) | |
| Feb 20, 2026 | 2025 (Q4) | -0.050.03 | 0.08 | -66.67% (-0.05) | |
| Nov 07, 2025 | 2025 (Q3) | 0.360.07 | 0.78 | -90.91% (-0.71) | |
| Aug 01, 2025 | 2025 (Q2) | 1.051.10 | 1.38 | -20.00% (-0.28) | |
| May 02, 2025 | 2025 (Q1) | 0.730.83 | -0.5 | 266.07% (+1.32) | |
| Feb 21, 2025 | 2024 (Q4) | -0.320.08 | -0.09 | 190.00% (+0.17) | |
| Nov 01, 2024 | 2024 (Q3) | 0.580.78 | -0.32 | 344.44% (+1.10) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

